Clinical trial
A Comparison of Ropinirole Immediate Release With Ropinirole Prolonged Release…
NCT00331149 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00331149 |
|---|---|
| Title | A Comparison of Ropinirole Immediate Release With Ropinirole Prolonged Release in Patients With Advanced Parkinson's |
| Official title | A Randomised, Double-Blind, Double-Dummy, Parallel Group Comparison of 24 Weeks of Treatment With Ropinirole Immediate Release Tablets (REQUIP IR) or Ropinirole Prolonged Release Tablets (SK&F-101468) in Advanced Stage Parkinson's Disease Subjects Who Are Not Adequately Controlled on L-dopa. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Parkinson Disease |
| Intervention type | Drug |
| Interventions | Ropinirole prolonged release, ropinirole immediate release |
| Enrollment | 343 |
| Start date | Jun 20, 2006 |
| Primary completion | Aug 29, 2007 |
| Completion | Aug 29, 2007 |
| First posted | May 29, 2006 |
| Last update posted | Aug 22, 2017 |
| Countries | Bulgaria, Canada, Czechia, France, Germany, Hungary, Italy, Poland, Romania, Russia, South Africa, Spain and 2 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: